Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 18 hours agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...
GlaxoSmithKline Sues Pfizer and BioNTech Over Covid-19 Vaccine Technology
US News & World Report· 7 days agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 22 hours agoIt simply wasn’t affordable for the plans for a new plant to go ahead – something experts have...
GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales
Bloomberg Law· 7 days agohave reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine technology. The complaint relates to patents discovered by researchers who ...
What's Going On With Pfizer Stock On Thursday? - GSK (NYSE:GSK), Pfizer (NYSE:PFE)
Benzinga· 7 days agoGSK Plc GSK has reportedly taken legal action against Pfizer Inc PFE and BioNTech SE BNTX in a...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 17 hours ago, opens new tab lifted its annual earnings forecast on Wednesday and reported a first-quarter profit...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 7 days agoAfter hitting a two-year high in February, biotech stocks have pulled back markedly in April. In...
Scholz promises support for pharma sector in Germany as Merck invests
KFGO· 7 days agoBERLIN (Reuters) - German Chancellor Olaf Scholz said he was committed to supporting the...
Wall Street plunges after US inflation shock
The Telegraph via Yahoo Finance· 7 days agoUS stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 20 hours agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...